On March 23, 2021 David R. Koos was appointed as Chief Executive Officer of Regen Biopharma, Inc. David R. Koos has served as Chairman of the Board of Directors, Chief Executive Officer, President, Secretary and Treasurer of SYBLEU INC., from June 12, 2020 to the present. David R. Koos served as Chief Financial Officer of SYBLEU INC. from June 12, 2020 to July 21, 2020. On March 23, 2021 Todd S. Caven resigned from his position as Chief Executive Officer of Regen BioPharma Inc.